A detailed history of Eam Investors, LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Eam Investors, LLC holds 89,389 shares of DERM stock, worth $709,748. This represents 0.08% of its overall portfolio holdings.

Number of Shares
89,389
Previous 95,067 5.97%
Holding current value
$709,748
Previous $682,000 7.33%
% of portfolio
0.08%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$6.9 - $8.54 $39,178 - $48,490
-5,678 Reduced 5.97%
89,389 $632,000
Q2 2025

Aug 12, 2025

BUY
$5.97 - $8.07 $567,549 - $767,190
95,067 New
95,067 $682,000
Q4 2023

Feb 13, 2024

BUY
$2.7 - $7.96 $298,374 - $879,651
110,509 New
110,509 $636,000

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $92.1M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.